These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 10487612

  • 1. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI.
    Br J Cancer; 1999 Sep; 81(1):54-61. PubMed ID: 10487612
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]

  • 3. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM, Hügel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T, Wernert N.
    Cancer Res; 1999 Nov 01; 59(21):5608-14. PubMed ID: 10554042
    [Abstract] [Full Text] [Related]

  • 4. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP, Currie MJ, Han C, Robinson BA, Scott PA, Harris AL, Fox SB.
    Clin Cancer Res; 2000 Nov 01; 6(11):4278-86. PubMed ID: 11106244
    [Abstract] [Full Text] [Related]

  • 5. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
    Ng IO, Poon RT, Lee JM, Fan ST, Ng M, Tso WK.
    Am J Clin Pathol; 2001 Dec 01; 116(6):838-45. PubMed ID: 11764072
    [Abstract] [Full Text] [Related]

  • 6. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G, Zhao M, Xu M, Yang Y, Wang M, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb 01; 25(2):89-93. PubMed ID: 11953105
    [Abstract] [Full Text] [Related]

  • 7. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 01; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 8. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S.
    Princess Takamatsu Symp; 1994 Jun 01; 24():162-70. PubMed ID: 8983073
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.
    J Pathol; 2003 Jun 01; 200(2):183-94. PubMed ID: 12754739
    [Abstract] [Full Text] [Related]

  • 11. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 12. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA, Valente PT, Feinstein GI, Dey T.
    Gynecol Oncol; 2000 Jan 01; 76(1):33-9. PubMed ID: 10620438
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D.
    Cancer Res; 1997 Dec 01; 57(23):5421-5. PubMed ID: 9393770
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.
    Winther H, Ahmed A, Dantzer V.
    Placenta; 1999 Jan 01; 20(1):35-43. PubMed ID: 9950143
    [Abstract] [Full Text] [Related]

  • 15. Thrombospondin-1 expression and clinical implications in malignant pleural mesothelioma.
    Ohta Y, Shridhar V, Kalemkerian GP, Bright RK, Watanabe Y, Pass HI.
    Cancer; 1999 Jun 15; 85(12):2570-6. PubMed ID: 10375104
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT, Richter L, Frutiger Y, Grogan TM.
    Cancer Res; 1999 Feb 01; 59(3):728-33. PubMed ID: 9973224
    [Abstract] [Full Text] [Related]

  • 17. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
    Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M.
    J Clin Invest; 1995 Sep 01; 96(3):1295-302. PubMed ID: 7657804
    [Abstract] [Full Text] [Related]

  • 18. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 01; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 19. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer.
    Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM.
    Clin Cancer Res; 1996 Oct 01; 2(10):1679-84. PubMed ID: 9816116
    [Abstract] [Full Text] [Related]

  • 20. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.
    Catalano A, Romano M, Martinotti S, Procopio A.
    Oncogene; 2002 Apr 25; 21(18):2896-900. PubMed ID: 11973650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.